Literature DB >> 21034685

Characteristics of children with elevated symptoms of mania: the Longitudinal Assessment of Manic Symptoms (LAMS) study.

Robert L Findling1, Eric A Youngstrom, Mary A Fristad, Boris Birmaher, Robert A Kowatch, L Eugene Arnold, Thomas W Frazier, David Axelson, Neal Ryan, Christine A Demeter, Mary Kay Gill, Benjamin Fields, Judith Depew, Shawn M Kennedy, Linda Marsh, Brieana M Rowles, Sarah McCue Horwitz.   

Abstract

OBJECTIVE: The aim of the Longitudinal Assessment of Manic Symptoms (LAMS) study is to examine differences in psychiatric symptomatology, diagnoses, demographics, functioning, and psychotropic medication exposure in children with elevated symptoms of mania (ESM) compared to youth without ESM. This article describes the initial demographic information, diagnostic and symptom prevalence, and medication exposure for the LAMS cohort that will be followed longitudinally.
METHOD: Guardians of consecutively ascertained new outpatients 6 to 12 years of age presenting for treatment at one of 10 university-affiliated mental health centers were asked to complete the Parent General Behavior Inventory-10-Item Mania Scale (PGBI-10M). Patients with scores ≥ 12 on the PGBI-10M (ESM+) and a matched sample of patients who screened negative (ESM-) were invited to participate. Patients were enrolled from December 13, 2005, to December 18, 2008.
RESULTS: 707 children (621 ESM+, 86 ESM-; mean [SD] age = 9.4 [2.0] years) were evaluated. The ESM+ group, compared to the ESM- group, more frequently met DSM-IV criteria for a mood disorder (P < .001), bipolar spectrum disorders (BPSD; P < .001), and disruptive behavior disorders (P < .01). Furthermore, they showed poorer overall functioning and more severe manic, depressive, attention-deficit/hyperactivity, disruptive behavioral, and anxiety symptoms. Nevertheless, rates of BPSD were relatively low in the ESM+ group (25%), with almost half of these BPSD patients (12.1% of ESM+ patients) meeting DSM-IV criteria for bipolar disorder not otherwise specified. ESM+ children with BPSD had significantly more of the following: current prescriptions for antipsychotics, mood stabilizers, and anticonvulsants (P < .001 for each); psychiatric hospitalizations (P < .001); and biological parents with elevated mood (P = .001 for mothers, P < .013 for fathers). ESM+ children with BPSD were also lower functioning compared to ESM+ children without BPSD.
CONCLUSIONS: Although ESM+ was associated with higher rates of BPSD than ESM-, 75% of ESM+ children did not meet criteria for BPSD. Results suggest that longitudinal assessment is needed to examine which factors are associated with diagnostic evolution to BPSD in children with elevated symptoms of mania. © Copyright 2010 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21034685      PMCID: PMC3057622          DOI: 10.4088/JCP.09m05859yel

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  34 in total

1.  Longitudinal Assessment of Manic Symptoms (LAMS) study: background, design, and initial screening results.

Authors:  Sarah McCue Horwitz; Christine A Demeter; Maria E Pagano; Eric A Youngstrom; Mary A Fristad; L Eugene Arnold; Boris Birmaher; Mary Kay Gill; David Axelson; Robert A Kowatch; Thomas W Frazier; Robert L Findling
Journal:  J Clin Psychiatry       Date:  2010-10-05       Impact factor: 4.384

2.  Further evidence of reliability and validity of the Child Symptom Inventory-4: parent checklist in clinically referred boys.

Authors:  Joyce Sprafkin; Kenneth D Gadow; Helen Salisbury; Jayne Schneider; Jan Loney
Journal:  J Clin Child Adolesc Psychol       Date:  2002-12

3.  Factor structure of the Young Mania Rating Scale for use with youths ages 5 to 17 years.

Authors:  Eric A Youngstrom; Carla Kmett Danielson; Robert L Findling; Barbara L Gracious; Joseph R Calabrese
Journal:  J Clin Child Adolesc Psychol       Date:  2002-12

4.  Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling sections.

Authors:  B Geller; B Zimerman; M Williams; K Bolhofner; J L Craney; M P DelBello; C Soutullo
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-04       Impact factor: 8.829

5.  Bipolar disorder during adolescence and young adulthood in a community sample.

Authors:  P M Lewinsohn; D N Klein; J R Seeley
Journal:  Bipolar Disord       Date:  2000-09       Impact factor: 6.744

6.  Prepubertal and young adolescent bipolarity versus ADHD: assessment and validity using the WASH-U-KSADS, CBCL and TRF.

Authors:  B Geller; K Warner; M Williams; B Zimerman
Journal:  J Affect Disord       Date:  1998-11       Impact factor: 4.839

7.  Manic symptoms in young males with ADHD predict functioning but not diagnosis after 6 years.

Authors:  Philip L Hazell; Vaughan Carr; Terry J Lewin; Ketrina Sly
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-05       Impact factor: 8.829

8.  Brief screening for family psychiatric history: the family history screen.

Authors:  M M Weissman; P Wickramaratne; P Adams; S Wolk; H Verdeli; M Olfson
Journal:  Arch Gen Psychiatry       Date:  2000-07

Review 9.  National Institute of Mental Health research roundtable on prepubertal bipolar disorder.

Authors: 
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-08       Impact factor: 8.829

10.  Correspondence between adolescent report, parent report, and teacher report of manic symptoms.

Authors:  Madhavan Thuppal; Gabrielle A Carlson; Joyce Sprafkin; Kenneth D Gadow
Journal:  J Child Adolesc Psychopharmacol       Date:  2002       Impact factor: 2.576

View more
  75 in total

1.  Parents' perceptions of benefit of children's mental health treatment and continued use of services.

Authors:  Sarah Horwitz; Christine Demeter; Margaret Hayden; Amy Storfer-Isser; Thomas W Frazier; Mary A Fristad; L Eugene Arnold; Eric A Youngstrom; Boris Birmaher; David Axelson; Robert L Findling
Journal:  Psychiatr Serv       Date:  2012-08       Impact factor: 3.084

2.  Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder.

Authors:  Thomas W Frazier; Paul T Shattuck; Sarah Carter Narendorf; Benjamin P Cooper; Mary Wagner; Edward L Spitznagel
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-12-13       Impact factor: 2.576

3.  Mental health service use by children with serious emotional and behavioral disturbance: results from the LAMS study.

Authors:  Amy N Mendenhall; Christine Demeter; Robert L Findling; Thomas W Frazier; Mary A Fristad; Eric A Youngstrom; L Eugene Arnold; Boris Birmaher; Mary Kay Gill; David Axelson; Robert A Kowatch; Sarah McCue Horwitz
Journal:  Psychiatr Serv       Date:  2011-06       Impact factor: 3.084

4.  Altered functioning of reward circuitry in youth offspring of parents with bipolar disorder.

Authors:  A Manelis; C D Ladouceur; S Graur; K Monk; L K Bonar; M B Hickey; A C Dwojak; D Axelson; B I Goldstein; T R Goldstein; G Bebko; M A Bertocci; M K Gill; B Birmaher; M L Phillips
Journal:  Psychol Med       Date:  2015-09-16       Impact factor: 7.723

5.  Abnormal deactivation of the inferior frontal gyrus during implicit emotion processing in youth with bipolar disorder: attenuated by medication.

Authors:  Danella M Hafeman; Genna Bebko; Michele A Bertocci; Jay C Fournier; Lisa Bonar; Susan B Perlman; Michael Travis; Mary Kay Gill; Vaibhav A Diwadkar; Jeffrey L Sunshine; Scott K Holland; Robert A Kowatch; Boris Birmaher; David Axelson; Sarah M Horwitz; L Eugene Arnold; Mary A Fristad; Thomas W Frazier; Eric A Youngstrom; Robert L Findling; Wayne Drevets; Mary L Phillips
Journal:  J Psychiatr Res       Date:  2014-08-08       Impact factor: 4.791

6.  Parsing dimensional vs diagnostic category-related patterns of reward circuitry function in behaviorally and emotionally dysregulated youth in the Longitudinal Assessment of Manic Symptoms study.

Authors:  Genna Bebko; Michele A Bertocci; Jay C Fournier; Amanda K Hinze; Lisa Bonar; Jorge R C Almeida; Susan B Perlman; Amelia Versace; Claudiu Schirda; Michael Travis; Mary Kay Gill; Christine Demeter; Vaibhav A Diwadkar; Gary Ciuffetelli; Eric Rodriguez; Thomas Olino; Erika Forbes; Jeffrey L Sunshine; Scott K Holland; Robert A Kowatch; Boris Birmaher; David Axelson; Sarah M Horwitz; L Eugene Arnold; Mary A Fristad; Eric A Youngstrom; Robert L Findling; Mary L Phillips
Journal:  JAMA Psychiatry       Date:  2014-01       Impact factor: 21.596

7.  The Bipolar Prodrome Symptom Interview and Scale-Prospective (BPSS-P): description and validation in a psychiatric sample and healthy controls.

Authors:  Christoph U Correll; Doreen M Olvet; Andrea M Auther; Marta Hauser; Taishiro Kishimoto; Ricardo E Carrión; Stephanie Snyder; Barbara A Cornblatt
Journal:  Bipolar Disord       Date:  2014-05-08       Impact factor: 6.744

8.  Diagnostic efficiency of the CBCL thought problems and DSM-oriented psychotic symptoms scales for pediatric psychotic symptoms.

Authors:  Stephanie Salcedo; Sabeen H Rizvi; Lindsey K Freeman; Jennifer K Youngstrom; Robert L Findling; Eric A Youngstrom
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-03-20       Impact factor: 4.785

9.  Amygdala-prefrontal cortical functional connectivity during implicit emotion processing differentiates youth with bipolar spectrum from youth with externalizing disorders.

Authors:  Danella Hafeman; Genna Bebko; Michele A Bertocci; Jay C Fournier; Henry W Chase; Lisa Bonar; Susan B Perlman; Michael Travis; Mary Kay Gill; Vaibhav A Diwadkar; Jeffrey L Sunshine; Scott K Holland; Robert A Kowatch; Boris Birmaher; David Axelson; Sarah M Horwitz; L Eugene Arnold; Mary A Fristad; Thomas W Frazier; Eric A Youngstrom; Robert L Findling; Mary L Phillips
Journal:  J Affect Disord       Date:  2016-10-11       Impact factor: 4.839

10.  Longitudinal trajectories of mood symptoms and global functioning in youth at high risk for bipolar disorder.

Authors:  Marc J Weintraub; Christopher D Schneck; Patricia D Walshaw; Kiki D Chang; Aimee E Sullivan; Manpreet K Singh; David J Miklowitz
Journal:  J Affect Disord       Date:  2020-08-13       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.